Atlas Trials

Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study

Clinical trial NCT02384499 · COMPLETED

Trial details

NCT number
NCT02384499
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fecal Incontinence
Start date
2014-12-01
Primary completion
2017-06-30
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.